NEW YORK -- When the final Phase 3 data came out last November showing the mRNA vaccines made by Pfizer/BioNTech and Moderna were more than 90% effective, Dr. Anthony Fauci had no words. He texted ...
Pfizer has axed 11 programs, including two pipeline assets from its $43 billion Seagen acquisition, work on a ...
Pfizer Inc said on Monday its experimental vaccine was more than 90% effective in preventing COVID-19 based on initial data from a large study, a major victory in the fight against the pandemic.
Scientists say mRNA technology could be setting up the immune system to fight deadly tumors—and they’ve got the data to prove ...
When you buy through links on our articles, Future and its syndication partners may earn a commission. MRNA technology was thrust into the limelight during the COVID-19 pandemic, but had been in ...
More than 20 COVID vaccines are in use globally, each one based on the ancestral coronavirus SARS-CoV-2 that surfaced in Wuhan, China, over two years ago. Among them, mRNA vaccines are believed to ...
Pfizer started its 25,000-person phase 3 trial Sept. 14 to test the efficacy of a flu vaccine candidate that uses the same mRNA technology as its COVID-19 vaccine. In mid-June, Moderna began enrolling ...
Moderna has filed a lawsuit against Pfizer and its German partner BioNTech for allegedly copying their COVID-19 vaccine. On Friday, Moderna issued a news release accusing Pfizer of infringing several ...
The Pfizer Covid vaccine increased the risk of heart problems for children sixfold in the first week of having the jab but led to fewer cases in the long term, research suggests.
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million, marking a major policy shift under Secretary Robert F. Kennedy Jr. that directly affects ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results